1[1]Meinnel, T., Patiny, L., Ragusa, S., et al. Design and synthesis of substrate analogue inhibitors of peptide deformylase. Biochemistry, 1999;38(14):4287
2[2]Solbiati, J.; Chapman-Smith, A.; Processing of the N termini of nascent polypeptide chains requires deformylation prior to methiunine removal. Mol Biol, 1999;290(3) :607～614
3[3]Groche D, Becker A, Schlichting I, et al. Isolation and crystallization of functionally competent Escherichia coli peptide deformylase forms containing either iron or nickel in the active site . Biochem Biophys Res Commum ,1998;246(2) :342
4[4]Eecker A, Schlichting I, Kabsch W, et al. Structure of peptide deformylase and identification of the substrate binding site. J Biol Chem.1998 ;273(19):11413～11416
5[5]Giglione C, Serero A, Pierre M, et al. Identification of eukaryotic peptide deformylases reveals universality of N-terminal protein processing mechanisms. J EMBO 2000; 19 (21):5916 ～ 5929
6[6]Meinnel, T. Peptide deformylase of eukaryotic protists: a target for new antiparasitic agents?. Parasitology Today, 2000; 16(4): 165～168
7[7]Clements, J.M.; Beckett, R.P.; Brown, A. et al, Antibiotic activity and characterization of BB-3497, a novel peptide deformylase inhibitor. Antimicrob Agents Chemother. 2001; 45(2) :563～570
8[8]Hackbarth, C.J.; Lewis, J.G.. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity . Antimicrob Agents Chemother, 2002, 46(9) :2752
9[9]Chen D, Hackbarth C, Ni ZJ, et al. Peptide deformylase inhibitors as antibacterial agents: identification of VRC3375, a proline-3-alkylsuccinyl hydroxamate derivative, by using an integrated combinatorial and medicinal chemistry approach. Antimicrob Agents Chemother. 2004; 48 ( 1 ): 250～261
10[10]Lofland D, Difuntorum S, waller A, et al. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698. J Antimicrob Chemother.2004;53(4) :664～668
